Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Cancer Chemotherapy and Pharmacology
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(22)
+
-
Availability
Open access
(7)
+
-
Metadata Only
(15)
+
-
Creation Date
2015
(5)
+
-
2014
(4)
+
-
2011
(2)
+
-
2016
(2)
+
-
2017
(2)
+
-
Faculty
Faculty of Science
(2)
+
-
Leiden University Medical Center (LUMC)
(20)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(20)
+
-
Topic
Pharmacokinetics
(7)
+
-
Breast cancer
(3)
+
-
Colorectal cancer
(3)
+
-
Uracil
(3)
+
-
2D strain imaging
(2)
+
-
Anthracyclines
(2)
+
-
Biomarkers
(2)
+
-
Cancer
(2)
+
-
Cardiotoxicity
(2)
+
-
Endoxifen
(2)
+
-
Histone
(2)
+
-
I-123-mIBG scintigraphy
(2)
+
-
Pan-deacetylase inhibitor
(2)
+
-
Panitumumab
(2)
+
-
Panobinostat
(2)
+
-
Phase I
(2)
+
-
Population pharmacokinetics
(2)
+
-
Sunitinib
(2)
+
-
Tamoxifen
(2)
+
-
Show more
Author
Gelderblom, H.
(13)
+
-
Guchelaar, H.J.
(12)
+
-
Hartigh, J. den
(4)
+
-
Baas, J.M.
(3)
+
-
Erp, N.P. van
(3)
+
-
Krens, L.L.
(3)
+
-
Moes, D.J.A.R.
(3)
+
-
Beijnen, J.H.
(2)
+
-
Bellersen, L.
(2)
+
-
Bulten, B.F.
(2)
+
-
Geus-Oei, L.F. de
(2)
+
-
Hess, D.
(2)
+
-
Hollander, M. den
(2)
+
-
Huitema, A.D.R.
(2)
+
-
Kapusta, L.
(2)
+
-
Konig-Quartel, J.M.C.
(2)
+
-
Kuilenburg, A.B.P. van
(2)
+
-
Laarhoven, H.W.M. van
(2)
+
-
Maring, J.G.
(2)
+
-
Mavinkurve-Groothuis, A.M.C.
(2)
+
-
Mu, S.
(2)
+
-
Oyen, W.J.G.
(2)
+
-
Porro, M.G.
(2)
+
-
Sabate-Llobera, A.
(2)
+
-
Sharma, S.
(2)
+
-
Staveren, M.C. van
(2)
+
-
Valera, S.Z.
(2)
+
-
Verberne, H.J.
(2)
+
-
Waldron, E.
(2)
+
-
Wit, D. de
(2)
+
-
Show more
Language
en
(22)
+
-
Search results
(1 - 22 of 22)
show grid
show list
save search
Assay performance and stability of uracil and dihydrouracil in clinical practice
Efficacy and toxicity of vemurafenib and cobimetinib in relation to plasma concentrations, after administration via feeding tube in patients with BRAF-mutated thyroid cancer: a case series and review of literature
Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors
Exposure-response analysis of endoxifen serum concentrations in early-breast cancer
A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup
Pharmacokinetics and safety of panitumumab in a patient with chronic kidney disease
The potential of multi-compound nanoparticles to bypass drug resistance in cancer
Population pharmacokinetics of lenalidomide in multiple myeloma patients
Everolimus pharmacokinetics and its exposure-toxicity relationship in patients with thyroid cancer
Pharmacokinetic and pharmacodynamic study of doxorubicin in children with cancer: results of a "European Pediatric Oncology Off-patents Medicines Consortium" trial
Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients
Relationship of promising methods in the detection of anthracycline-induced cardiotoxicity in breast cancer patients
The novel beta 2-selective proteasome inhibitor LU-102 decreases phosphorylation of I kappa B and induces highly synergistic cytotoxicity in combination with ibrutinib in multiple myeloma cells
Influence of metastatic disease on the usefulness of uracil pharmacokinetics as a screening tool for DPD activity in colorectal cancer patients
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and varying degrees of renal function
A phase I, open-label, multicenter study to evaluate the pharmacokinetics and safety of oral panobinostat in patients with advanced solid tumors and various degrees of hepatic function
Pharmacokinetics and safety of cetuximab in a patient with renal dysfunction
Pharmacokinetics of panitumumab in a patient with liver dysfunction: a case report
Midazolam as a phenotyping probe to predict sunitinib exposure in patients with cancer
The use of the C-13-dextromethorphan breath test for phenotyping CYP2D6 in breast cancer patients using tamoxifen: association with CYP2D6 genotype and serum endoxifen levels
Pharmacokinetics of orally administered uracil in healthy volunteers and in DPD-deficient patients, a possible tool for screening of DPD deficiency
Marginal increase of sunitinib exposure by grapefruit juice